LYTIR

Insider · SEC Form 4 · Chief Executive Officer

John E. Kao

Filed with the SEC as KAO JOHN E; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $17.5M of ALHC. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $17.5M in total.Jul: Insider sales $5.9MAug: Insider sales $4.1MSep: Insider sales $7.5MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $17.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ALHCSold: Alignment Healthcare, Inc. Sep 14, 2026 27,400 shares filed Sep 16, 2026 590,766 shares held indirectly after, as filed 10b5-1 plan filing $356K
  2. ALHCSold: Alignment Healthcare, Inc. Sep 11, 2026 385,270 shares filed Sep 11, 2026 1,223,473 shares held directly after, as filed 10b5-1 plan filing $4.9M
  3. ALHCSold: Alignment Healthcare, Inc. Sep 10, 2026 172,600 shares filed Sep 11, 2026 618,166 shares held indirectly after, as filed 10b5-1 plan filing $2.2M
  4. ALHCSold: Alignment Healthcare, Inc. Aug 10, 2026 298,000 shares filed Aug 10, 2026 790,766 shares held indirectly after, as filed 10b5-1 plan filing $4.1M
  5. ALHCSold: Alignment Healthcare, Inc. Jul 10, 2026 298,000 shares filed Jul 14, 2026 2 transactions 10b5-1 plan filing $5.9M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.